Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter

To determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support. DATA SOURCES: The first two patients in the United States treated with the novel Sera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care Explor
Main Authors: Olson, Stephen W., Oliver, James D., Collen, Jacob, Bunin, Jessica, Gleeson, Todd D., Foster, Brian E., Simmons, Mark P., Chen, Hua W., Ficke, Jennifer B., Brown, Tara E., Nau, Mark T., Cebula, Brennan R., Kielstein, Jan, Chung, Kevin K.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7396271/
https://ncbi.nlm.nih.gov/pubmed/32766569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000180
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados